Living with Advanced Hormone-Sensitive Prostate Cancer and Treatment with Abiraterone and Androgen Deprivation Therapy:
- PDF / 516,455 Bytes
- 11 Pages / 595.276 x 790.866 pts Page_size
- 74 Downloads / 217 Views
COMMENTARY
Living with Advanced Hormone-Sensitive Prostate Cancer and Treatment with Abiraterone and Androgen Deprivation Therapy: The Patient, Nursing and Physician Perspective Tony Collier . Shievon Smith . Michelle Greenwood . Kenrick Ng
Received: September 24, 2020 / Accepted: September 30, 2020 Ó The Author(s) 2020
ABSTRACT This article is co-authored by a patient with metastatic hormone-sensitive prostate cancer who is receiving abiraterone and androgen deprivation therapy treatment in Manchester, UK. The patient relates his personal experiences struggling with the diagnosis, his experience with treatment and the physical, emotional and psychosexual impact on his life. After his diagnosis, the patient has become an outspoken advocate and fundraiser for prostate cancer awareness and wants to ensure that novel treatments with proven efficacy and tolerability, such as abiraterone, are available for all men in his condition. The specialist nursing and
T. Collier Prostate Cancer UK, 53 Tooley Street, London SE1 2QN, UK S. Smith M. Greenwood K. Ng St Bartholomew’s Hospital, Barts Health NHS Trust, London EC1A 7BE, UK K. Ng (&) UCL Cancer Institute, 72 Huntley Street, London WC1E 6DD, UK e-mail: [email protected]
physician perspectives, provided by healthcare professionals based in London who are not directly involved in this patient’s care, were written in response to the challenges and concerns highlighted by this patient. The role of the specialist nurse as a key healthcare professional in the cancer patient journey, particularly in managing the complex physical and emotional side effects of treatment, is highlighted in this perspective piece. The physician reviews the current difficulties of establishing an effective screening programme in prostate cancer, the common side effects of hormone treatment and the significant progress and challenges in novel drug development and prescription in metastatic hormone-sensitive prostate cancer. While written primarily from the perspective of a patient and healthcare professionals in England, many messages in this commentary would resonate with patients and professionals involved in the care of prostate cancer worldwide.
Keywords: Abiraterone; Patient perspective; Prostate cancer; PSA; Screening; Survivorship
Oncol Ther
Key Summary Points This article is co-authored by a patient with advanced prostate cancer on abiraterone and androgen deprivation therapy. It details his struggles with the initial diagnosis, his experiences with treatment, the impact this has had on his personal and family life and his role as a patient advocate. The perspective of clinical nurse specialists is also provided, to highlight the important role of these professionals in managing the complex physical and emotional side effects of treatment in the patient journey. The physician responds to concerns and queries relating to screening programmes, side effects of treatment and challenges relating to treatment availability and reimbursement.
DIGITAL FEATURES This article is published with d
Data Loading...
